Literature DB >> 17406861

Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro.

Emi E Nakayama1, Wassila Carpentier, Dominique Costagliola, Tatsuo Shioda, Aikichi Iwamoto, Patrice Debre, Kazuhisa Yoshimura, Brigitte Autran, Shuzo Matsushita, Ioannis Theodorou.   

Abstract

Polymorphisms in human genes have been shown to affect the rate of disease progression to acquired immune deficiency syndrome in human immunodeficiency virus type 1 (HIV-1)-infected individuals. Recently, tripartite motif 5alpha (TRIM5alpha) was identified as a factor that confers resistance to HIV-1 infection in Old World monkey cells. Subsequently, Sawyer et al. (Curr Biol 16:95-100, 2006) reported a single nucleotide polymorphism (H43Y) in the human TRIM5alpha gene and TRIM5alpha protein with 43Y was found to lose its ability to restrict HIV-1. In the present study, we reevaluated effects of this allele on in vitro anti-HIV-1 activity as well as on HIV-1 disease progression in European and Asian cohorts of HIV-1-infected individuals. Our epidemiological and molecular biological findings clearly indicate H43Y has a very minor effect on anti-HIV-1 activity of TRIM5alpha, suggesting that this allele is immaterial, at least in HIV-1-infected Europeans and Asians.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406861     DOI: 10.1007/s00251-007-0217-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  16 in total

1.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain.

Authors:  Sara L Sawyer; Lily I Wu; Michael Emerman; Harmit S Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-02       Impact factor: 11.205

2.  Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.

Authors:  Emi E Nakayama; Hiroyuki Miyoshi; Yoshiyuki Nagai; Tatsuo Shioda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.

Authors:  Emi E Nakayama; Hikoichiro Maegawa; Tatsuo Shioda
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

5.  Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.

Authors:  Hassan Javanbakht; Ping An; Bert Gold; Desiree C Petersen; Colm O'Huigin; George W Nelson; Stephen J O'Brien; Gregory D Kirk; Roger Detels; Susan Buchbinder; Sharyne Donfield; Sergey Shulenin; Byeongwoon Song; Michel J Perron; Matthew Stremlau; Joseph Sodroski; Michael Dean; Cheryl Winkler
Journal:  Virology       Date:  2006-08-02       Impact factor: 3.616

6.  TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.

Authors:  Michel J Perron; Matthew Stremlau; Byeongwoon Song; Wes Ulm; Richard C Mulligan; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

7.  Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.

Authors:  M Magierowska; I Theodorou; P Debré; F Sanson; B Autran; Y Rivière; D Charron; D Costagliola
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

8.  Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.

Authors:  Emily C Speelmon; Devon Livingston-Rosanoff; Shuying Sue Li; Quyen Vu; John Bui; Daniel E Geraghty; Lue Ping Zhao; M Juliana McElrath
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

10.  A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.

Authors:  Melvyn W Yap; Sébastien Nisole; Jonathan P Stoye
Journal:  Curr Biol       Date:  2005-01-11       Impact factor: 10.834

View more
  13 in total

1.  A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.

Authors:  Heather Price; Philip Lacap; Jeff Tuff; Charles Wachihi; Joshua Kimani; Terry B Ball; Ma Luo; Francis A Plummer
Journal:  AIDS       Date:  2010-07-31       Impact factor: 4.177

2.  TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Nadeene Riddick; Kenta Matsuda; Sonya Whitted; Ronald J Plishka; Alicia Buckler-White; Matthew F Starost; Vanessa M Hirsch
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

Review 3.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

4.  A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.

Authors:  Emi E Nakayama; Toshiaki Nakajima; Gurvinder Kaur; Jun-ich Mimaya; Hiroshi Terunuma; Narinder Mehra; Akinori Kimura; Tatsuo Shioda
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-26       Impact factor: 2.205

5.  A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.

Authors:  Judith N Torimiro; Hassan Javanbakht; Felipe Diaz-Griffero; Jonghwa Kim; Jean K Carr; Mary Carrington; Julie Sawitzke; Donald S Burke; Nathan D Wolfe; Michael Dean; Joseph Sodroski
Journal:  Virology       Date:  2009-07-03       Impact factor: 3.616

6.  Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles.

Authors:  Clémence Granier; Emilie Battivelli; Camille Lécuroux; Alain Venet; Olivier Lambotte; Marion Schmitt-Boulanger; Constance Delaugerre; Jean-Michel Molina; Lisa A Chakrabarti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 7.  Host genetics influences on HIV type-1 disease.

Authors:  Jacques Fellay
Journal:  Antivir Ther       Date:  2009

8.  TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.

Authors:  Ronaldo Celerino da Silva; Antonio Victor Campos Coelho; Luiz Cláudio Arraes; Lucas André Cavalcanti Brandão; Sergio Crovella; Rafael Lima Guimarães
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

9.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

10.  Interpreting missense mutations in Human TRIM5alpha by computational methods.

Authors:  Philip A Chan
Journal:  BMC Res Notes       Date:  2008-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.